Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
暂无分享,去创建一个
[1] M. Kamata,et al. A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. , 2005, Microbes and infection.
[2] G. Chrousos,et al. Vpr Protein of Human Immunodeficiency Virus Type 1 Binds to 14-3-3 Proteins and Facilitates Complex Formation with Cdc25C: Implications for Cell Cycle Arrest , 2005, Journal of Virology.
[3] Y. Wang,et al. Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[4] M. Lairmore,et al. The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth , 2005, Cell Death and Differentiation.
[5] U. Schubert,et al. Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells , 2000, Journal of Virology.
[6] D. Green,et al. HIV-1 Vpr Induces Apoptosis through Caspase 9 in T Cells and Peripheral Blood Mononuclear Cells* , 2002, The Journal of Biological Chemistry.
[7] D. Weiner,et al. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] D O Morgan,et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity , 1995, Journal of virology.
[9] H. Okayama,et al. Genetic Studies with the Fission YeastSchizosaccharomyces pombe Suggest Involvement of Wee1, Ppa2, and Rad24 in Induction of Cell Cycle Arrest by Human Immunodeficiency Virus Type 1 Vpr , 2000, Journal of Virology.
[10] N. Jullian,et al. Structure, biological functions and inhibition of the HIV-1 proteins Vpr and NCp7. , 1997, Biochimie.
[11] G. Chrousos,et al. AIDS-related insulin resistance and lipodystrophy syndrome. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.
[12] Philippe P Roux,et al. Activation of Transcription Factors NF-κB and NF-IL-6 by Human Immunodeficiency Virus Type 1 Protein R (Vpr) Induces Interleukin-8 Expression , 2000, Journal of Virology.
[13] A. Badley,et al. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.
[14] F. Boisvert,et al. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation , 1995, Journal of virology.
[15] M. Emerman. HIV-1, Vpr and the cell cycle , 1996, Current Biology.
[16] É. Cohen,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection , 1999, Journal of Virology.
[17] P. Gage,et al. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Kinzler,et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.
[19] O. Narayan,et al. Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat (*) , 1995, The Journal of Biological Chemistry.
[20] R. Connor,et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.
[21] W. Greene,et al. Nucleocytoplasmic Shuttling by Human Immunodeficiency Virus Type 1 Vpr , 2001, Journal of Virology.
[22] Anthony J. Muslin,et al. 14-3-3 proteins: regulation of subcellular localization by molecular interference. , 2000, Cellular signalling.
[23] W. Paxton,et al. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.
[24] J. Luban,et al. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B , 1995, Journal of virology.
[25] S. Elledge,et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.
[26] É. Cohen,et al. The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells , 1998, Journal of Virology.
[27] K L Gould,et al. Regulating the onset of mitosis. , 1999, Current opinion in cell biology.
[28] O. Narayan,et al. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. , 1994, The Journal of biological chemistry.
[29] O. Narayan,et al. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. , 1994, The Journal of biological chemistry.
[30] P. Russell,et al. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein , 1999, Nature.
[31] R. Zhao,et al. Viral infections and cell cycle G2/M regulation , 2005, Cell Research.
[32] I. Chen,et al. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest , 1997, Journal of virology.
[33] L. Ratner,et al. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions , 1993, Journal of virology.
[34] J. Fernández,et al. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. , 1999, Genes & development.
[35] Guido Kroemer,et al. Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2 , 2001, The Journal of experimental medicine.
[36] D. Green,et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB , 1997, Nature Medicine.
[37] G. Kroemer,et al. The HIV-1 Viral Protein R Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore , 2000, The Journal of experimental medicine.
[38] R. Gorelick,et al. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles , 1995, Journal of virology.
[39] Meng Chen,et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle , 1995, Journal of virology.
[40] M. Chen,et al. Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. , 2000, Virus research.
[41] A. Kumagai,et al. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. , 2001, Molecular biology of the cell.
[42] S. Masters,et al. 14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.
[43] B. Roques,et al. Direct activation of protein phosphatase‐2A0 by HIV‐1 encoded protein complex NCp7:vpr , 1997, FEBS letters.
[44] Mong-Hong Lee,et al. Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression* , 2000, The Journal of Biological Chemistry.
[45] G. Blobel,et al. Viral protein R regulates nuclear import of the HIV‐1 pre‐integration complex , 1998, The EMBO journal.
[46] D. Weiner,et al. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Göttlinger,et al. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr , 1996, Journal of virology.
[48] S. Mahalingam,et al. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. , 1995, Virology.
[49] G. Blobel,et al. Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex* , 1998, The Journal of Biological Chemistry.
[50] F. Hanaoka,et al. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair , 1997, Journal of virology.
[51] P. Gage,et al. The Amino-Terminal Region of Vpr from Human Immunodeficiency Virus Type 1 Forms Ion Channels and Kills Neurons , 1999, Journal of Virology.
[52] C. Depienne,et al. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. , 2001, Virology.
[53] J. Sodroski,et al. Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.
[54] S. Wain-Hobson,et al. The molecular biology of HIV-1. , 1994 .
[55] G. Chrousos,et al. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. , 1998, Virology.
[56] P. Henklein,et al. Structural Characterization of the HIV-1 Vpr N Terminus , 2003, Journal of Biological Chemistry.
[57] K. Khalili,et al. Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.
[58] Robert J. Ferl,et al. Evolution of the 14-3-3 Protein Family: Does the Large Number of Isoforms in Multicellular Organisms Reflect Functional Specificity? , 2000, Journal of Molecular Evolution.
[59] J. Feigon,et al. Biochemical and structural analysis of the interaction between the UBA(2) domain of the DNA repair protein HHR23A and HIV-1 Vpr. , 2000, Biochemistry.
[60] M. Kamata,et al. A Carboxy-Terminally Truncated Form of the Human Immunodeficiency Virus Type 1 Vpr Protein Induces Apoptosis via G1 Cell Cycle Arrest , 2000, Journal of Virology.
[61] B. Roques,et al. The Zinc Fingers of HIV Nucleocapsid Protein NCp7 Direct Interactions with the Viral Regulatory Protein Vpr* , 1997, The Journal of Biological Chemistry.
[62] D. Weiner,et al. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[63] I. Chen,et al. Depletion of Wee-1 Kinase Is Necessary for both Human Immunodeficiency Virus Type 1 Vpr- and Gamma Irradiation-Induced Apoptosis , 2003, Journal of Virology.
[64] M. Morris,et al. An Essential Phosphorylation-site Domain of Human cdc25C Interacts with Both 14-3-3 and Cyclins* , 2000, The Journal of Biological Chemistry.
[65] B. Roques,et al. NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr. , 1999, European journal of biochemistry.
[66] Wesley I. Sundquist,et al. Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag , 2001, Journal of Virology.
[67] M. Ramanathan,et al. Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling* , 2002, The Journal of Biological Chemistry.
[68] R. Pomerantz,et al. Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis in Human Neuronal Cells , 2000, Journal of Virology.
[69] G. Chrousos,et al. Protein 14-3-3σ Interacts with and Favors Cytoplasmic Subcellular Localization of the Glucocorticoid Receptor, Acting as a Negative Regulator of the Glucocorticoid Signaling Pathway* , 2003, Journal of Biological Chemistry.
[70] É. Cohen,et al. Role of auxiliary proteins in retroviral morphogenesis. , 1996, Current topics in microbiology and immunology.
[71] S. Moreno,et al. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.
[72] L. M. Mansky,et al. The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate , 2000, Journal of Virology.
[73] M. Emerman,et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[74] The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. , 1996, Biochemical and biophysical research communications.
[75] A. Nebreda,et al. Regulation of the meiotic cell cycle in oocytes. , 2000, Current opinion in cell biology.
[76] J. Decaprio,et al. Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site , 1999, Molecular and Cellular Biology.
[77] Jeremy Luban,et al. Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression* , 2003, Journal of Biological Chemistry.
[78] N. Walworth,et al. Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage. , 1999, Genes & development.
[79] F. Rey,et al. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. , 1996, Journal of molecular biology.
[80] J. Sodroski,et al. Identification of HIV-1 vpr product and function. , 1990, Journal of acquired immune deficiency syndromes.
[81] R. Goodman,et al. CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.
[82] P. Silver,et al. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. , 1998, Genes & development.
[83] Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. , 1996, Virology.
[84] J. Feigon,et al. Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr , 1998, Nature Structural Biology.
[85] F. Mammano,et al. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles , 1995, Journal of virology.
[86] D. Weiner,et al. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr , 1997, Journal of virology.
[87] J. Kim,et al. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. , 2002, DNA and cell biology.
[88] É. Cohen,et al. Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor* , 1999, The Journal of Biological Chemistry.
[89] Ling-jun Zhao,et al. Pro-apoptotic Activity of HIV-1 Auxiliary Regulatory Protein Vpr Is Subtype-dependent and Potently Enhanced by Nonconservative Changes of the Leucine Residue at Position 64* , 2003, Journal of Biological Chemistry.
[90] R. Knoblauch,et al. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr , 1995, Journal of virology.
[91] F. Rey,et al. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme , 1996, Journal of virology.
[92] L. Zhao,et al. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. , 1998, Gene.
[93] R. Murali,et al. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[94] G. Chrousos,et al. The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor , 1999 .
[95] I. Chen,et al. Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation , 2000, Journal of Virology.
[96] I. Chen,et al. Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[97] O. J. Semmes,et al. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response , 2005, Oncogene.
[98] M. Yanagida,et al. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. , 2001, Virology.
[99] M. Yaffe,et al. The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.
[100] M. A. Vodicka,et al. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest , 1997, Journal of virology.
[101] M. Yaffe,et al. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. , 1999, Molecular cell.
[102] B. Roques,et al. NMR structure of the HIV-1 regulatory protein VPR. , 2003, Journal of molecular biology.
[103] L. Stark,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Viral Protein R (Vpr) Interacts with Lys-tRNA Synthetase: Implications for Priming of HIV-1 Reverse Transcription , 1998, Journal of Virology.
[104] M. Emerman,et al. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection , 1995, Journal of virology.
[105] M. Nowak,et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo , 1998, Nature Medicine.
[106] R. Pomerantz,et al. Diversity of HIV-1 Vpr Interactions Involves Usage of the WXXF Motif of Host Cell Proteins* , 1998, The Journal of Biological Chemistry.
[107] S. Mahalingam,et al. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. , 1995, Virology.
[108] M. Bukrinsky,et al. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. , 2000, Journal of molecular biology.
[109] N. McKenna,et al. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functionsProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[110] Xiaojian Yao,et al. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. , 1998, Journal of molecular biology.
[111] C. Peng,et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.
[112] R. Desrosiers,et al. Copyright � 1995, American Society for Microbiology Progression to AIDS in the Absence of a Gene for vpr or vpx , 1994 .
[113] G. Chrousos,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Accessory Protein Vpr Induces Transcription of the HIV-1 and Glucocorticoid-Responsive Promoters by Binding Directly to p300/CBP Coactivators , 2002, Journal of Virology.
[114] P. Graves,et al. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding , 2001, Oncogene.
[115] B. Roques,et al. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. , 1999, Journal of molecular biology.
[116] J. Pines,et al. Cyclins and the G2/M transition. , 1997, Cancer surveys.